The 15 analysts offering 1 year price forecasts for BIOMERIEUX have a max estimate of 132.0 and a min estimate of 90.00.
Analyst rating
Based on 15 analysts giving stock ratings to BIOMERIEUX in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
11
Buy
1
Hold
2
Sell
1
Strong sell
0
EPS
Forecast
H2 '20
H1 '21
H2 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
0.60
1.20
1.80
2.40
Reported
Estimate
Currency: EUR
H2 '20
H1 '21
H2 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
1.93
1.36
—
1.82
—
—
Estimate
—
—
—
—
2.05
—
Surprise
—
—
—
—
—
—
Revenue
Forecast
H2 '20
H1 '21
H2 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
600.00 M
1.20 B
1.80 B
2.40 B
Reported
Estimate
Currency: EUR
H2 '20
H1 '21
H2 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
1.66 B
1.77 B
—
1.90 B
—
—
Estimate
—
—
—
1.88 B
2.06 B
—
Surprise
—
—
—
+1.38%
—
—
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter BIOMERIEUX revenue is expected to reach 2.06 B EUR. Check out BIOMERIEUX revenue and earnings and make informed decisions.
According to analysts, BIM price target is 121.80 EUR with a max estimate of 132.00 EUR and a min estimate of 90.00 EUR. Check if this forecast comes true in a year, meanwhile watch BIOMERIEUX stock price chart and keep track of the current situation with BIM news and stock market news.
We've gathered opinions of 15 analysts rating BIM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.